Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | |
| Sales | 57,230 |
| Cost of Goods | 26,113 |
| Gross Profit | 31,117 |
| Operating Expenses | 45,528 |
| Operating Income | -14,298 |
| Interest Expense | 2,282 |
| Other Income | 171 |
| Pre-tax Income | -16,409 |
| Net Income Continuous | -16,409 |
| Net Income | $-16,409 |
| EPS Basic Total Ops | -83.50 |
| EPS Basic Continuous Ops | -83.46 |
| EPS Diluted Total Ops | -83.50 |
| EPS Diluted Continuous Ops | -83.46 |
| EBITDA(a) | $-14,298 |